Rhythm PharmaceuticalsRYTM
那斯達克 · USD
117.62
+12.85
(+12.26%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Rhythm PharmaceuticalsRYTM
117.62
+12.85
(+12.26%)
財務數據
損益表
- 0.19
- 0.23
- 0.24
- 0.26
- 0.29
- 0.33
- 0.42
- 0.33
- 0.49
- 0.51
- 67.60
- 17.07
- 7.69
- 7.15
- 11.98
- 14.35
- 25.80
- -21.82
- 48.31
- 5.76
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 51,298 | 48,502 | 32,704 | 41,830 | 33,251 | 29,078 | 25,967 | 24,234 | 22,503 | 19,222 |
營業成本 | 5,499 | 5,543 | 3,648 | 3,787 | 3,828 | 2,946 | 2,807 | 3,233 | 2,412 | 2,236 |
營業毛利 | 45,799 | 42,959 | 29,056 | 38,043 | 29,423 | 26,132 | 23,160 | 21,001 | 20,091 | 16,986 |
營業費用 | 98,452 | 88,255 | 76,060 | 79,298 | - | - | 163,047 | 62,266 | 64,056 | 63,582 |
研發費用 | 46,026 | 42,308 | 36,973 | 41,168 | 37,931 | 30,193 | 128,665 | 29,892 | 33,572 | 33,542 |
推銷及管理費用 | 52,426 | 45,947 | 39,087 | 38,130 | 35,377 | 36,415 | 34,382 | 32,374 | 30,484 | 30,040 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -52,653 | -45,296 | -47,004 | -41,255 | -43,885 | -40,476 | -139,887 | -41,265 | -43,965 | -46,596 |
其他收入及費用 | 4,602 | 4,818 | 2,995 | 3,320 | 5,663 | 13,297 | 3,570 | 4,378 | 3,063 | 3,281 |
利息費用 | 4,742 | 5,817 | 5,409 | 5,447 | 5,798 | 4,603 | 4,755 | 4,550 | 2,893 | 3,388 |
稅前純益 | -52,793 | -46,295 | -49,418 | -43,382 | -44,020 | -31,782 | -141,072 | -41,437 | -43,795 | -46,703 |
所得稅 | 111 | 337 | 80 | -90 | -343 | 479 | 300 | 196 | 368 | - |
稅後純益 | -52,904 | -46,632 | -49,498 | -43,292 | -43,677 | -32,261 | -141,372 | -41,633 | -44,163 | -46,703 |
基本每股稅後盈餘(元) | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.55 | -2.35 | -0.70 | -0.76 | -0.82 |
稀釋每股稅後盈餘(元) | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.54 | -2.35 | -0.70 | -0.76 | -0.82 |
基本平均股數(千股) | 66261.00 | 63684.00 | 63059.00 | 61596.00 | 61219.00 | 61011.00 | 60143.00 | 59211.00 | 57874.00 | 56867.00 |
稀釋平均股數(千股) | 66261.00 | 63684.00 | 63059.00 | 61596.00 | 61219.00 | 61011.00 | 60143.00 | 59211.00 | 57874.00 | 56867.00 |
還原基本每股稅後盈餘(元) | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.55 | -2.35 | -0.70 | -0.76 | -0.82 |
還原稀釋每股稅後盈餘(元) | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.54 | -2.35 | -0.70 | -0.76 | -0.82 |
還原基本平均股數(千股) | 66,261 | 63,684 | 63,059 | 61,596 | 61,219 | 61,011 | 60,143 | 59,211 | 57,874 | 56,867 |
還原稀釋平均股數(千股) | 66,261 | 63,684 | 63,059 | 61,596 | 61,219 | 61,011 | 60,143 | 59,211 | 57,874 | 56,867 |
EBITDA(千元) | -47,747 | -40,099 | -43,626 | -37,552 | -37,837 | -26,789 | -135,912 | -36,470 | -40,460 | -42,873 |